-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, TOcHFbPnbV+luENVrhPfdg3isszLuMo+7IyXI0mDmaB/7akTv14Ara1F4XsbSCAz oRGSO22qYqOoZVpqEAgQqg== 0001157523-09-004135.txt : 20090527 0001157523-09-004135.hdr.sgml : 20090527 20090527080019 ACCESSION NUMBER: 0001157523-09-004135 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20090527 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20090527 DATE AS OF CHANGE: 20090527 FILER: COMPANY DATA: COMPANY CONFORMED NAME: IXYS CORP /DE/ CENTRAL INDEX KEY: 0000945699 STANDARD INDUSTRIAL CLASSIFICATION: SEMICONDUCTORS & RELATED DEVICES [3674] IRS NUMBER: 770140882 STATE OF INCORPORATION: DE FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-26124 FILM NUMBER: 09853250 BUSINESS ADDRESS: STREET 1: 3540 BASSETT ST CITY: SANTA CLARA STATE: CA ZIP: 95054 BUSINESS PHONE: 4089540500 MAIL ADDRESS: STREET 1: 3540 BASSETT STREET CITY: SANTA CLARA STATE: CA ZIP: 95054 FORMER COMPANY: FORMER CONFORMED NAME: PARADIGM TECHNOLOGY INC /DE/ DATE OF NAME CHANGE: 19951031 8-K 1 a5973350.htm IXYS CORP. 8-K

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549


FORM 8-K


CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934


Date of Report:  May 27, 2009
(Date of earliest event reported)


IXYS CORPORATION
(Exact name of registrant as specified in its charter)


Delaware

000-26124

77-0140882

(State or other jurisdiction

of incorporation)

(Commission File No.)

 

(IRS Employer

Identification No.)

1590 Buckeye Drive

Milpitas, California 95035

(Address of principal executive offices and zip code)


Registrant’s telephone number, including area code: (408) 457-9000

Not Applicable
(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))


Item 2.02     Results of Operations and Financial Conditions.

The following information is furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.

On May 27, 2009, IXYS issued a press release.  The text of IXYS’s press release is attached hereto as Exhibit 99.1.

Item 9.01     Financial Statements and Exhibits.

(c)

Exhibits

 
 

The following exhibit is furnished (not filed) herewith:

 
Exhibit

Number

Description

99.1 Text of press release issued by IXYS Corporation, dated May 27, 2009.


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

IXYS CORPORATION

 

By: /s/ Uzi Sasson

 

Uzi Sasson, Chief Operating Officer and

Chief Financial Officer

(Principal Financial Officer)

 

Date:

May 27, 2009

EX-99.1 2 a5973350ex99_1.htm EXHIBIT 99.1

Exhibit 99.1

IXYS Corporation Announces March Quarter and Year Results

MILPITAS, Calif. & BIEL, Switzerland--(BUSINESS WIRE)--May 27, 2009--IXYS Corporation (NASDAQ:IXYS), an international power semiconductor company, today reported net revenues of $58.2 million for the fourth fiscal quarter ended March 31, 2009, as compared with net revenues of $79.3 million for the same period in the prior fiscal year.

For the fiscal year ended March 31, 2009, IXYS reported net revenues of $273.6 million, as compared with net revenues of $304.5 million for the prior fiscal year.

“We are not immune to the present difficult economic cycle. However, the IXYS business model of diversified products, customers, markets and geographies has enabled us to endure this lengthy recession with a relatively low decline in annual revenues. We have also taken significant steps to reduce our expenses,” stated Dr. Nathan Zommer, Chairman and CEO of IXYS. “Taking advantage of the economic situation, we have continued our selective R&D investments in new technologies and new capabilities in order to position IXYS for better growth opportunities in new applications, relative to our competitors.”

Gross profit was $4.7 million, or 8.1% of net revenues, for the quarter ended March 31, 2009, as compared to gross profit of $24.0 million, or 30.3% of net revenues, for the same quarter in the prior fiscal year. The gross profit for the quarter ended March 31, 2009 included unusual excess inventory write-downs of $11.9 million, which were taken in response to the deterioration in the business environment, as well as inventory charges of $323,000 in the normal course of business. Excluding the $11.9 million unusual charge, gross profit for the quarter ended March 31, 2009 would have been $16.6 million, or 28.5% of net revenues. Gross profit for the fiscal year ended March 31, 2009 was $66.0 million, or 24.1% of net revenues, as compared to a gross profit of $87.1 million, or 28.6% of net revenues, for the prior fiscal year.

The results for the quarter ended March 31, 2009 included pre-tax adjustments reducing net income of $4.0 million (after tax of $3.6 million) for the impairment of goodwill and intangible assets and $11.9 million (after tax of $7.8 million) for inventory write-downs, and adjustments totaling $4.1 million related to taxes that also reduced net income. Adjustments in the quarter increasing net income included $2.2 million (after tax of $1.5 million) for funds received in reimbursement of litigation related expenses. All these items are unusually large adjustments that are not typically encountered under normal operations.

"We believe that a comparison of year to year non-GAAP results is a better indicator of our results from product driven revenues,” opined Dr. Zommer. Net loss for the quarter ended March 31, 2009 was $10.9 million, or $0.36 loss per diluted share. On a non-GAAP basis (excluding the unusual adjustments), net income for the quarter was $3.1 million, or $0.10 per diluted share. For the same quarter of the prior fiscal year, net income was $10.1 million, or $0.32 income per diluted share; on a non-GAAP basis (excluding unusual adjustments, which were litigation entries), net income was $5.5 million or $0.17 per diluted share.


Net loss for the fiscal year ended March 31, 2009 was $3.3 million, or $0.11 loss per diluted share; on a non-GAAP basis (excluding the unusual adjustments), the net income for the year was $15.8 million, or $0.49 per diluted share. This compares to net income of $23.3 million, or $0.71 per diluted share, for the fiscal year ending March 31, 2008; and on a non-GAAP basis (excluding the unusual litigation entries), the net income for the year was $15.1 million or $0.46 per diluted share.

“As a result of the reduction in revenues and lack of better visibility, we increased our excess inventory reserves by $11.9 million. We also examined the goodwill and intangible assets recorded in prior acquisitions and determined them to be impaired; therefore, they were written off. The writeoff of goodwill and intangibles was $4.0 million. Additionally, we have been reimbursed $2.2 million for litigation related expenses and have made tax related adjustments totaling $4.1 million. Except for these unusually large items, our net income for the quarter ended March 31, 2009 would have been $3.1 million, or $0.10 per diluted share,” stated Uzi Sasson, COO and CFO.

Regarding revenue projections, Mr. Sasson said, “With the changing economic conditions, we have found that our ability to project revenues has declined. Consequently, we are ceasing the practice of projecting revenues.”

About IXYS Corporation

Since its founding in Silicon Valley, IXYS Corporation has been developing power semiconductor technology-driven products to improve power conversion efficiency, generate clean energy, improve automation and provide advanced products for the transportation, medical and telecommunication industries. IXYS is a worldwide pioneer in the development of power MOSFETs, IGBTs, solid state relays, GaAs based RF FETs and amplifiers and high voltage integrated circuits that are key to reducing the world’s dependence on fossil fuels. IXYS has provided its array of products to the renewable energy market since 1996 - products that enabled high efficiency wind energy generation and high efficiency solar photovoltaic electricity generation.

Non-GAAP Financial Information

Included above and within the attached schedules are certain non-GAAP financial figures. Management believes non-GAAP net income and non-GAAP net income per share are useful measures of operating performance because they exclude the impact of the write-off for the impairment of goodwill and intangible assets, the impact of various adjustments to inventory, adjustments related to taxes and litigation related adjustments, all of which are unusually large adjustments that are not typically encountered under normal operations. However, these non-GAAP measures should be considered in addition to, not as a substitute for, or superior to net income and net income per share, or other financial measures prepared in accordance with GAAP.


Safe Harbor Statement

The foregoing press release contains forward-looking statements, including those related to our ability to position ourselves for better growth opportunities and visibility. Actual results may vary materially from those contained in the forward-looking statements, due to changes in customer delivery schedules, the cancellation of orders, the absence of future orders, an unanticipated decline in our business and disruptions in our production caused by our vendors, among other things. Further information on other factors that could affect IXYS is detailed and included in IXYS’ Form 10-Q for the fiscal quarter ended December 31, 2008, as filed with the Securities and Exchange Commission. IXYS undertakes no obligation to publicly release the results of any revisions to these forward-looking statements.


IXYS CORPORATION
CONDENSED CONSOLIDATED BALANCE SHEETS
(in thousands)
(unaudited)
 
  March 31,   March 31,
2009 2008
ASSETS
Current assets:
Cash and cash equivalents $ 55,577 $ 57,234
Accounts receivable, net 37,251 50,270
Other receivables 671 2,282
Inventories, net 75,601 86,516
Prepaid expenses and other current assets 3,323 4,133
Deferred income taxes   12,797   7,578
Total current assets 185,220 208,013
Plant and equipment, net 52,912 58,033
Other assets 6,728 14,238
Deferred income taxes   7,972   13,546
 
Total assets $ 252,832 $ 293,830
 
LIABILITIES AND STOCKHOLDERS' EQUITY
 
Current liabilities:
Current portion of capitalized lease obligations $ 3,739 $ 4,890
Current portion of notes payable to bank 1,455 1,286
Accounts payable 13,767 21,489
Accrued expenses and other current liabilities   15,342   17,956
Total current liabilities 34,303 45,621
Capitalized lease and other long term obligations, net of current portion 26,862 30,752
Pension liabilities   13,175   17,228
Total liabilities   74,340   93,601
 
Common stock 361 354
Additional paid-in capital 132,177 132,125
Retained earnings 43,984 50,494
Accumulated other comprehensive income   1,970   17,256
Stockholders' equity   178,492   200,229
 
Total liabilities and stockholders' equity $ 252,832 $ 293,830

IXYS CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(in thousands, except per share data)
(unaudited)
 
  Three Months Ended       Twelve Months Ended
Mar. 31   Mar. 31 Mar. 31   Mar. 31
2009   2008 2009   2008
   
Net revenues $ 58,244 $ 79,254 $ 273,552 $ 304,456
Cost of goods sold   53,499       55,278     207,594       217,332  
Gross profit   4,745       23,976     65,958       87,124  
Operating expenses:
Research, development and engineering 4,373 5,575 19,931 21,124
Selling, general and administrative 8,912 10,633 39,613 42,093
Impairment charges 2,691 - 6,440 -
Litigation provision   -       (7,062 )   -       (12,957 )
Total operating expenses   15,976       9,146     65,984       50,260  
 
Operating income (loss) (11,231 ) 14,830 (26 ) 36,864
Other income (expense), net   2,335       (974 )   3,590       (2,885 )
 
Income (loss) before income tax provision (8,896 ) 13,856 3,564 33,979
Provision for income tax   2,014       3,737     6,913       10,690  
 
Net income (loss) $ (10,910 )   $ 10,119   $ (3,349 )   $ 23,289  
 
Net income (loss) per share - basic $ (0.36 )   $ 0.33   $ (0.11 )   $ 0.73  
 
Weighted average shares used in per share calculation - basic   30,633       31,083     31,087       31,906  
 
Net income (loss) per share - diluted $ (0.36 )   $ 0.32   $ (0.11 )   $ 0.71  
 
Weighted average shares used in per share calculation - diluted   30,633       31,842     31,087       33,031  

GAAP reconciliation to non-GAAP
(In thousands, except per share amounts)
 
  Quarter Ended   Twelve Months Ended
31-Mar-09   31-Mar-08 31-Mar-09   31-Mar-08
 
Net (loss) income, as reported (GAAP) $ (10,910 ) $ 10,119 $ (3,349 ) $ 23,289
Adjustment to GAAP net income (net of taxes)
Goodwill impairment charges 2,691 - 6,440 -
Additional excess inventory reserves 7,796

-

9,767 -
Accelerated amortization of intangibles 887

-

887

-

Reimbursement of litigation related expenses (1,464 )

-

(1,464 )

-

Release of litigation reserves - (4,601 ) - (8,153 )
Tax related adjustments to GAAP 4,142

-

3,482

-

       
Non-GAAP net income $ 3,142   $ 5,518   $ 15,763   $ 15,136  
 
Net (loss) income per share-basic, as reported (GAAP) $ (0.36 ) $ 0.33 $ (0.11 ) $ 0.73
Adjustment to GAAP net income (net of taxes)
Goodwill impairment charges 0.09 - 0.21 -
Additional excess inventory reserves 0.25 - 0.32 -
Accelerated amortization of intangibles 0.03 - 0.03 -
Reimbursement of litigation related expenses (0.05 ) - (0.05 ) -
Release of litigation reserves - (0.15 ) - (0.26 )
Tax related adjustments to GAAP 0.14 - 0.11 -
       
Net income per share-basic, (non-GAAP) $ 0.10   $ 0.18   $ 0.51   $ 0.47  
 
Net (loss) income per share-diluted, as reported (GAAP) $ (0.36 ) $ 0.32 $ (0.11 ) $ 0.71
Adjustment to GAAP net income (net of taxes)
Goodwill impairment charges 0.09 (0.15 ) 0.20 -
Additional excess inventory reserves 0.26

-

0.31 -
Accelerated amortization of intangibles 0.03

-

0.03 -
Reimbursement of litigation related expenses (0.05 )

-

(0.05 ) -
Release of litigation reserves - - - (0.25 )
Tax related adjustments to GAAP 0.13

-

0.11 -
       
Net income per share-diluted, (non-GAAP) $ 0.10   $ 0.17   $ 0.49   $ 0.46  
 
Weighted average shares used in per share calculation
Basic 30,633 31,083 31,087 31,906
Dilutive weighted average share   624     759     905     1,125  
Diluted 31,257 31,842 31,992 33,031

CONTACT:
IXYS Corporation
Uzi Sasson, 408-457-9000
COO & CFO

-----END PRIVACY-ENHANCED MESSAGE-----